Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
- The first conference will be the
H.C. Wainwright Global Life Sciences Conference , which is taking placeMarch 9-10, 2021 . The Company will conduct one-on-one meetings with institutional investors at this conference and a pre-recorded corporate overview presentation byRichard A. Miller , M.D., president and chief executive officer of Corvus, will be available to play on-demand starting at7:00 am ET onTuesday, March 9 . - The second conference will be the 33rd Annual
Roth Virtual Conference , which is taking placeMarch 15-17, 2021 .Dr. Miller will participate in a fireside chat at2:30 pm ET /11:30 am PT onTuesday, March 16 and the Company will conduct one-on-one meetings with institutional investors at the conference. In addition, a pre-recorded corporate overview presentation byDr. Miller will be made available beginning onMonday, March 8, 2021 .
A webcast of the presentations and the fireside chat noted above will be available via the investor relations section of the Corvus website and replays will be available for 90 days following the events.
About Corvus Pharmaceuticals
INVESTOR CONTACT:
Chief Financial Officer
+1-650-900-4522
llea@corvuspharma.com
MEDIA CONTACT:
W2O pure
+1-949-903-4750
sseapy@purecommunications.com
Source: Corvus Pharmaceuticals, Inc.